Probing interactions between viral DNA and human immunodeficiency virus type 1 integrase using dinucleotides

Molecular Pharmacology

Volumn 51, Issue 4, 1997, Pages 567-575

  Mazumder, Abhijit ^a   Uchida, Hiroyuki ^b   Neamati, Nouri ^a   Sunder, Sanjay ^a   Jaworska Maslanka, Maria ^c   Wickstrom, Eric ^c   Zeng, Fan ^d   Jones, Roger A ^d   Mandes, Robert F ^e   Chenault, H Keith ^e   Pommier, Yves ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e UNIVERSITY OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DINUCLEOTIDE; INTEGRASE; RECOMBINANT PROTEIN; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CYTOPATHOGENIC EFFECT; DNA BINDING; ENZYME INHIBITION; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETROVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0030902155     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.4.567     Document Type: Article

References (37)

1. Johnston, M. I., and D. F. Hoth. Present status and future prospects for HIV therapies. Science (Washington D. C.) 260:1286-1293 (1993).
2. Mazumder, A., N. Neamati, J.-P. Sommadossi, G. Gosselin, R. F. Schinazi, J.-L. Imbach, and Y. Pommier. Effects of nucleotide analogs on human immunodeficiency virus integrase. Mol. Pharmacol. 49:621-628 (1996).
3. Robinson, W. E., Jr., M. G. Reinecke, S. Abdel-Malek, Q. Jia, and S. A. Chow. Inhibitors of HIV replication that inhibit HIV integrase. Proc. Natl. Acad. Sci. USA 93:6326-6331 (1996).
4. Bouziane, M., D. I. Cherny, J. F. Mouscadet, and C. Auclair. Alternate strand DNA triple helix-mediated inhibition of HIV-1 U5 long terminal repeat integration in vitro. J. Biol. Chem. 271:10359-10364 (1996).
5. Varmus, H. E., and P. O. Brown. Retroviruses, in Mobile DNA (D. Berg, and M. Howe, eds.). American Society of Microbiology, Washington, DC, 53-108 (1989).
6. Katz, R. A., and A. M. Skalka. The retroviral enzymes. Annu. Rev. Biochem. 63:133-173 (1994).
7. Rice, P., R. Craigie, and D. R. Davies. Retroviral integrases and their cousins. Curr. Opin. Struct. Biol. 6:76-83 (1996).
8. Mazumder, A., D. Cooney, R. Agbaria, M. Gupta, and Y. Pommier. Inhibition of human immunodeficiency virus type 1 integrase by 3′-azido-3′-deoxythymidylate. Proc. Natl. Acad. Sci. USA 91:5771-5775 (1994).
9. Cushman, M., W. M. Golebiewski, Y. Pommier, A. Mazumder, D. Reymen, E. De Clerq, L. Graham, and W. G. Rice. Cosalane analogs with enhanced potencies as inhibitors of HIV-1 protease and integrase. J. Med. Chem. 38:443-452 (1995).
10. LaFemina, R. L., P. L. Graham, K. LeGrow, J. C. Hastings, A. Wolfe, S. D. Young, E. A. Emini, and D. J. Hazuda. Inhibition of human immunodeficiency virus integrase by bis-catechols. Antimicrob. Agents Chemother. 39:320-324 (1995).
11. Mazumder, A., A. Gazit, A. Levitzki, M. Nicklaus, J. Yung, G. Kohlhagen, and Y. Pommier. Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase. Biochemistry 34:15111-15122 (1995).
12. Mazumder, A., K. Raghavan, J. N. Weinstein, K. W. Kohn, and Y. Pommier. Inhibition of human immunodeficiency virus type 1 integrase by curcumin. Biochem. Pharmacol. 49:1165-1170 (1995).
13. Allen, S. J. W., S. H. Krawczyk, L. R. McGee, N. Bischofberger, A. S. Mulato, and J. M. Cherrington. Inhibition of RNase H activity by nucleotide dimers and monomers. Antiviral Chem. Chemother. 7:37-45 (1996).
14. Engelman, A., K. Mizuuchi, and R. Craigie. HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell 67:1211-1221 (1991).
15. Vink, C., E. Yeheskiely, G. A. van der Marel, J. H. van Boom, and R. H. Plasterk. Site-specific hydrolysis and alcoholysis of human immunodeficiency virus DNA termini mediated by the viral integrase protein. Nucleic Acids Res. 19:6691-6698 (1991).
16. Chow, S. A., K. A. Vincent, V. Ellison, and P. O. Brown. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science (Washington D. C.) 255:723-726 (1992).
17. Bushman, F. D., A. Engelman, I. Palmer, P. Wingfield, and R. Craigie. Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc. Natl. Acad. Sci. USA 90:3428-3432 (1993).
18. Fesen, M., Y. Pommier, F. Leteurtre, S. Hiroguchi, J. Yung, and K. W. Kohn. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem. Pharmacol. 48:595-608 (1994).
19. Yoshinaga, T., Y. Kimura-Ohtani, and T. Fujiwara. Detection and characterization of a functional complex of human immunodeficiency virus type 1 integrase and its DNA substrate by UV cross-linking. J. Virol. 68:5690-5697 (1994).
20. Mitsuya, H., and S. Broder. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc. Natl. Acad. Sci. USA 83:1911-1915 (1986).
21. LaFemina, R. L., P. L. Callahan, and M. G. Cordingley. Substrate specificity of recombinant human immunodeficiency virus integrase protein. J. Virol. 65:5624-5630 (1991).
22. Vink, C., G. D. van, Y. Elgersma, and R. H. Plasterk. Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage. J. Virol. 65:4636-4644 (1991).
23. Nielsen, P. E. DNA analogues with nonphosphodiester backbones. Annu. Rev. Biophys. Biomol. Struct. 24:167-183 (1995).
24. Sobol, R. W., W. L. Fisher, N. L. Reichenbach, A. Kumar, W. A. Beard, S. H. Wilson, R. Charubala, W. Pfleiderer, and R. J. Suhadolnik. HIV-1 reverse transcriptase: inhibition by 2′,5′-oligoadenylates. Biochemistry 32:12112-12118 (1993).
25. Engelman, A., and R. Craigie. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J. Virol. 66:6361-6369 (1992).
26. Engelman, A., A. B. Hickman, and R. Craigie. The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding. J. Virol. 68:5911-5917 (1994).
27. Mazumder, A., and Y. Pommier. Processing of deoxyuridine mismatches and abasic sites by human immunodeficiency virus type-1 integrase. Nucleic Acids Res. 23:2865-2871 (1995).
28. van Den Ent, F. M. I., C. Vink, and R. H. A. Plasterk. DNA substrate requirements for different activities of the human immunodeficiency virus type 1 integrase protein. J. Virol. 68:7825-7832 (1994).
29. Ellison, V., and P. O. Brown. A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro. Proc Natl. Acad. Sci. USA 91:7316-7320 (1994).
30. Carteau, S., J. F. Mouscadet, H. Goulaouic, F. Subra, and C. Auclair. Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction. Arch. Biochem. Biophys. 305:606-610 (1993).
31. Bushman, F. D., and R. Craigie. Integration of human immunodeficiency virus DNA: adduct interference analysis of required DNA sites. Proc. Natl. Acad. Sci. USA 89:3458-3462 (1992).
32. Mazumder, A., M. Gupta, and Y. Pommier. Methylphosphonodiester substitution near the conserved CA dinucleotide in the HIV LTR alters both extent of 3′-processing and choice of nucleophile by HIV-1 integrase. Nucleic Acids Res. 22:4441-4448 (1994).
33. Lipford, J. R., S. T. Worland, and C. M. Farnet. Nucleotide binding by the HIV-1 integrase protein in vitro. J. Acq. Immune Defic. Syndr. 7:1215-1223 (1994).
34. Mazumder, A., M. Gupta, D. M. Perrin, D. S. Sigman, M. Rabinovitz, and Y. Pommier. Inhibition of human immunodeficiency virus type 1 integrase by a hydrophobic cation: the phenanthroline-cuprous complex. AIDS Res. Hum. Retroviruses 11:115-125 (1995).
35. Thormar, H., J. Balzarini, A. Holy, J. Jindrich, I. Rosenberg, Z. Debyser, J. Desmyter, and E. DeClercq. Inhibition of visna virus replication by 2′,3′-dideoxynucleosides and acyclic nucleoside phosphonate analogs. Antimicrob. Agents Chemother. 37:2540-25444 (1993).
36. Bishop, J. S., J. K. Guy-Caffey, J. O. Ojwang, S. R. Smith, M. E. Hogan, P. A. Cossum, R. F. Rando, and N. Chaudhary. Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide. J. Biol. Chem. 271:5698-5703 (1996).
37. Mazumder, A., N. Neamati, J. O. Ojwang, S. Sunder, R. F. Rando, and Y. Pommier. Inhibition of human immunodeficiency virus type 1 integrase by guanosine quartet structures. Biochemistry 43:13762-13771 (1996).